OBJECTIVES: To evaluate clinical predictors of poor sleep quality and quality of life (QOL) in patients with hypertrophic cardiomyopathy (HCM). METHODS: Consecutive stable patients with HCM were evaluated for the risk of obstructive sleep apnea (OSA) by the Berlin Questionnaire, daytime sleepiness by the Epworth Sleepiness Scale, sleep quality by the Pittsburgh Sleep Questionnaire Index and QOL by the Minnesota Living with Heart Failure Questionnaire. Asymptomatic subjects without HCM were used as controls. RESULTS: We studied 84 patients with HCM and 42 controls who were similar with regard to gender (49 vs. 50% males), age [52 (38-62) vs. 47 (33-58) years] and body mass index (27 ± 4 vs. 27 ± 5). HCM diagnosis, high risk for OSA and female gender were independently associated with poor sleep quality in the entire population. Among patients with HCM, poor QOL was independently associated with poor sleep quality, New York Heart Association functional class and diuretic therapy. CONCLUSION: Poor sleep quality is very common in patients with HCM and may have a negative impact on the QOL, which in turn is an important marker of prognosis in patients with cardiomyopathies.
OBJECTIVES: To evaluate clinical predictors of poor sleep quality and quality of life (QOL) in patients with hypertrophic cardiomyopathy (HCM). METHODS: Consecutive stable patients with HCM were evaluated for the risk of obstructive sleep apnea (OSA) by the Berlin Questionnaire, daytime sleepiness by the Epworth Sleepiness Scale, sleep quality by the Pittsburgh Sleep Questionnaire Index and QOL by the Minnesota Living with Heart Failure Questionnaire. Asymptomatic subjects without HCM were used as controls. RESULTS: We studied 84 patients with HCM and 42 controls who were similar with regard to gender (49 vs. 50% males), age [52 (38-62) vs. 47 (33-58) years] and body mass index (27 ± 4 vs. 27 ± 5). HCM diagnosis, high risk for OSA and female gender were independently associated with poor sleep quality in the entire population. Among patients with HCM, poor QOL was independently associated with poor sleep quality, New York Heart Association functional class and diuretic therapy. CONCLUSION: Poor sleep quality is very common in patients with HCM and may have a negative impact on the QOL, which in turn is an important marker of prognosis in patients with cardiomyopathies.
Authors: Jordy Mehawej; Jane S Saczynski; Catarina I Kiefe; Hawa O Abu; Mayra Tisminetzky; Weijia Wang; Benita A Bamgbade; Eric Ding; Darleen Lessard; Edith Mensah Otabil; Connor Saleeba; Robert J Goldberg; David D McManus Journal: J Clin Sleep Med Date: 2022-02-01 Impact factor: 4.324
Authors: Daokun Sun; Hartzell V Schaff; Virend K Somers; Rick A Nishimura; Jeffrey B Geske; Joseph A Dearani; Steve R Ommen Journal: CJC Open Date: 2022-07-11
Authors: Taofeek O Awotidebe; Victor O Adeyeye; Rufus A Adedoyin; Suraj A Ogunyemi; Kayode I Oke; Rita N Ativie; Goodness B Adeola; Mukadas O Akindele; Michael O Balogun Journal: Hong Kong Physiother J Date: 2016-11-22
Authors: Dirceu Thiago Pessoa de Melo; Flavia Baggio Nerbass; Ana Luiza Carrari Sayegh; Francis Ribeiro de Souza; Viviane Tiemi Hotta; Vera Maria Curi Salemi; Félix José Alvarez Ramires; Ricardo Ribeiro Dias; Geraldo Lorenzi-Filho; Charles Mady; Fábio Fernandes Journal: PLoS One Date: 2019-10-11 Impact factor: 3.240
Authors: Flávia B Nerbass; Rodrigo P Pedrosa; Pedro R Genta; Murillo O Antunes; Edmundo Arteaga-Fernández; Luciano F Drager; Geraldo Lorenzi-Filho Journal: Clinics (Sao Paulo) Date: 2013-07 Impact factor: 2.365